A Subjective Observational Study of Patients Using Medicated Footbath/Footwash Treatment in Podiatry Care

The Purpose of This Study is to Evaluate the Level of Relief Perceived by Patients Using Medicated Footbath/Footwash With or Without an Oral Medication for the Treatment of: Toenail Fungus Ingrown Toenails Cellulitis Athletes' Foot Pitted Keratolysis Diabetic Ulcers Open Infected Sores Abscesses Joint Infections Wound Care

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03781024

Enrollment

5000

Registered

2018-12-19

Start date

2018-12-01

Completion date

2022-06-01

Last updated

2018-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abscess, Cellulitis, Diabetic Foot Ulcer, Pitted Keratolysis, Toenail Fungal Infection

Brief summary

The purpose of this study is to evaluate the level of relief perceived by patients using medicated footbath/footwash with or without an oral medication for the treatment of podiatry issues.

Detailed description

Footwash/Footbath for treatment of; Toenail fungus Ingrown toenails Cellulitis Athletes' foot Pitted Keratolysis Diabetic ulcers Open infected sores Abscesses Joint infections Wound care

Interventions

COMBINATION_PRODUCTFootwash

footbath/footwash can help cleanse the wound, remove dead tissue, increase circulation and puts the wound in direct contact with medication to promote faster healing.

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Inclusion criteria

Participants must be diagnosed with an ICD10 code indicative of Toenail Fungus, Ingrown Toenail, Cellulitis, Athletes Foot, Pitted Keratolysis, Diabetic Ulcers, Open infected sores, Abscesses, and Joint infections * Participants must be starting a new regimen of a medicated footwash/foothbath * Participants must be expecting to receive therapy for at least 12 weeks * Participants must be between 18 and 64 years of age * Participants must be able to provide sound verbal informed consent

Exclusion criteria

\- Participants must not be a beneficiary of government funded healthcare program (i.e. Medicare, Medicaid, etc.) • Participants must not have a diagnosis of cancer within the past 5 years

Design outcomes

Primary

Measure	Time frame	Description
Patients' perspective through a patient led Survey of Health and quality of life via patient reported outcome measures using Visual analogue scale given at Baseline and follow up. Measuring effectiveness and quality of life from 0 to 10	36 months	Collecting and analyzing quantitative and qualitative data to draw generalized outcome measures, on real world data. Data from the subject surveys will analyze and measure the effectiveness through a subjective observation via patients' perspective survey on footwash with or without oral medication and if it helped with the reduction or elimination of infections.

Secondary

Measure	Time frame	Description
Visual Analogue scales	36 months	By utilizing the Visual analogue scale from the patients' perspective will generate real world data

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026